Average Co-Inventor Count = 11.64
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (12 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (10 from 2,405 patents)
3. Pharmacopeia Drug Discovery, Inc. (3 from 52 patents)
4. Pharmacopeia Inc. (2 from 101 patents)
5. Merck Sharp + Dohme B.v. (1 from 55 patents)
22 patents:
1. 10556957 - Anti-CD27 antibodies
2. 9969749 - Inhibitors of IRAK4 activity
3. 9943516 - Inhibitors of IRAK4 activity
4. 9932350 - Inhibitors of IRAK4 activity
5. 9926330 - Inhibitors of IRAK4 activity
6. 9206142 - Anilinopiperazine derivatives and methods of use thereof
7. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
8. 8623857 - N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
9. 8440443 - MEK1 polypeptides
10. 8318735 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
11. 8227605 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
12. 8088611 - Kinase domain polypeptide of human protein kinase B gamma (AKT3)
13. 7824491 - Method for crystallizing aurora 2 kinase catalytic domain polypeptide
14. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
15. 7776589 - Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)